乐普生物2022年上半年聚焦核心管线开发，加速商业化落地
Aug 25, 2022 17:46 HKT |  |
|
樂普生物2022年上半年聚焦核心管線開發，加速商業化落地
Aug 25, 2022 17:45 HKT | |
|
兆科眼科公布2022中期业绩
Aug 24, 2022 20:39 HKT |  |
|
兆科眼科公佈2022中期業績
Aug 24, 2022 20:38 HKT | |
|
Zhaoke Ophthalmology Announces 2022 Interim Results
Aug 24, 2022 20:37 HKT | |
|
重磅 深睿医疗6大创新任务荣登工信部、药监局揭榜名单
Aug 24, 2022 12:52 HKT | |
|
重磅 深睿醫療6大創新任務榮登工信部、藥監局揭榜名單
Aug 24, 2022 12:51 HKT | |
|
中国抗体宣布SN1011针对视神经脊髓炎谱系疾病的新药研究申请获国家药监局批准
Aug 24, 2022 08:07 HKT |  |
|
中國抗體宣佈SN1011針對視神經脊髓炎譜系疾病的新藥研究申請獲國家藥監局批准
Aug 24, 2022 08:06 HKT | |
|
Sinomab Announces IND Application of SN1011 for the Treatment of Neuromyelitis Optica Spectrum Disorder Approved by NMPA
Aug 24, 2022 08:05 HKT | |
|
Avantor and Avantor Foundation Make a Difference by Providing Critical Health Services for Vulnerable Communities in Singapore
Aug 24, 2022 07:55 HKT |  |
|
Oculis公佈II期數據抗腫瘤壞死因子(anti-TNFa)眼藥滴劑利卡明利單抗(OCS-02)可緩解嚴重干眼病患者的持續眼部不適
Aug 23, 2022 20:38 HKT |  |
|
Oculis announces publication of Phase 2 data showing topical eye drops anti-TNFa agent licaminlimab (OCS-02) relieves persistent ocular discomfort in severe dry eye disease
Aug 23, 2022 20:37 HKT | |
|
中国生物制药（1177.HK）公布2022年中期业绩，收入上升5.9%至人民币151.94亿元
Aug 23, 2022 19:53 HKT |  |
|
中國生物製藥（1177.HK）公布2022年中期業績，收入上升5.9%至人民幣151.94億元
Aug 23, 2022 19:52 HKT | |
|
Sino Biopharmaceutical (1177.HK) Announces 2022 lnterim Results, Revenue up by 5.9% to RMB15.19 billion
Aug 23, 2022 19:51 HKT | |
|
Sirnaomics获纳入恒生指数系列成份股
Aug 22, 2022 09:49 HKT | |
|
Sirnaomics獲納入恒生指數系列成份股
Aug 22, 2022 09:48 HKT | |
|
Sirnaomics Becoming A Constituent of Hang Seng Family of Indexes
Aug 22, 2022 09:47 HKT | |
|
沛嘉医疗公布2022年中期业绩：TaurusOne(R)及TaurusElite(R)屡创月度植入量新高
Aug 22, 2022 09:31 HKT |  |
|